APO Research
Talk to an analyst

APO RESEARCH · REPORT

Atracurium Besylate Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Atracurium Besylate Injection Industry Growth and Trends Forecast to 2032

20 December 2025108 pages

Choose your research edition.

Industry ResearchAtracurium Besylate Injection Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Atracurium Besylate Injection Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Atracurium Besylate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Atracurium Besylate Injection Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Atracurium Besylate Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Atracurium Besylate Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Atracurium Besylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Atracurium Besylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Atracurium Besylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Atracurium Besylate Injection include Qilu Pharma, Pfizer, Hengrui Medicine, GSK, SGPharma, Samarth Life Sciences, Lexicare Pharma, HBM Pharma and Gland Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Atracurium Besylate Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Atracurium Besylate Injection market size, estimates, and forecasts are presented in terms of sales volume (L) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Atracurium Besylate Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Atracurium Besylate Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Atracurium Besylate Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Atracurium Besylate Injection Market by Company

Qilu Pharma

Pfizer

Hengrui Medicine

GSK

SGPharma

Samarth Life Sciences

Lexicare Pharma

HBM Pharma

Gland Pharma

Flagship Biotech

Centurion Healthcare

American Remedies Healthcare

Atracurium Besylate Injection Segment by Type

2.5ml:12.5mg

5ml:25mg

Atracurium Besylate Injection Segment by Application

Surgery

Medical Examination

Atracurium Besylate Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atracurium Besylate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Atracurium Besylate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atracurium Besylate Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Atracurium Besylate Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Atracurium Besylate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 2.5ml:12.5mg Table 2. Major Company of 5ml:25mg Table 3. Global Atracurium Besylate Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Atracurium Besylate Injection Sales by Type (2021-2026) & (L) Table 5. Global Atracurium Besylate Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Atracurium Besylate Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Atracurium Besylate Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Atracurium Besylate Injection Price by Type (2021-2026) & (US$/ml) Table 9. Global Atracurium Besylate Injection Sales by Type (2027-2032) & (L) Table 10. Global Atracurium Besylate Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Atracurium Besylate Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Atracurium Besylate Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Atracurium Besylate Injection Price by Type (2027-2032) & (US$/ml) Table 14. North America Atracurium Besylate Injection Sales by Type (2021-2026) & (L) Table 15. North America Atracurium Besylate Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Atracurium Besylate Injection Sales by Type (2021-2026) & (L) Table 17. Europe Atracurium Besylate Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Atracurium Besylate Injection Sales by Type (2021-2026) & (L) Table 19. Asia-Pacific Atracurium Besylate Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Atracurium Besylate Injection Sales by Type (2021-2026) & (L) Table 21. Latin America Atracurium Besylate Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Atracurium Besylate Injection Sales by Type (2021-2026) & (L) Table 23. Middle East and Africa Atracurium Besylate Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Atracurium Besylate Injection Industry Trends Table 25. Atracurium Besylate Injection Industry Drivers Table 26. Atracurium Besylate Injection Industry Opportunities and Challenges Table 27. Atracurium Besylate Injection Industry Restraints Table 28. Global Atracurium Besylate Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Atracurium Besylate Injection Revenue Market Share by Company (2021-2026) Table 30. Global Atracurium Besylate Injection Sales by Company (2021-2026) & (L) Table 31. Global Atracurium Besylate Injection Sales Share by Company (2021-2026) Table 32. Global Atracurium Besylate Injection Market Price by Company (2021-2026) & (US$/ml) Table 33. Global Atracurium Besylate Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Atracurium Besylate Injection Major Company Production Sites and Headquarters Table 35. Global Atracurium Besylate Injection Company, Product Type & Application Table 36. Global Atracurium Besylate Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Atracurium Besylate Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Atracurium Besylate Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Atracurium Besylate Injection Sales by Region (2021-2026) & (L) Table 41. Global Atracurium Besylate Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Atracurium Besylate Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Atracurium Besylate Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Atracurium Besylate Injection Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 45. Global Atracurium Besylate Injection Sales by Region (2027-2032) & (L) Table 46. Global Atracurium Besylate Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Atracurium Besylate Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Atracurium Besylate Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Atracurium Besylate Injection Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2027-2032) Table 50. Global Atracurium Besylate Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Atracurium Besylate Injection Sales by Application (2021-2026) & (L) Table 52. Global Atracurium Besylate Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Atracurium Besylate Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Atracurium Besylate Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Atracurium Besylate Injection Price by Application (2021-2026) & (US$/ml) Table 56. Global Atracurium Besylate Injection Sales by Application (2027-2032) & (L) Table 57. Global Atracurium Besylate Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Atracurium Besylate Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Atracurium Besylate Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Atracurium Besylate Injection Price by Application (2027-2032) & (US$/ml) Table 61. North America Atracurium Besylate Injection Sales by Application (2021-2026) & (L) Table 62. North America Atracurium Besylate Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Atracurium Besylate Injection Sales by Application (2021-2026) & (L) Table 64. Europe Atracurium Besylate Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Atracurium Besylate Injection Sales by Application (2021-2026) & (L) Table 66. Asia-Pacific Atracurium Besylate Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Atracurium Besylate Injection Sales by Application (2021-2026) & (L) Table 68. Latin America Atracurium Besylate Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Atracurium Besylate Injection Sales by Application (2021-2026) & (L) Table 70. Middle East and Africa Atracurium Besylate Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Qilu Pharma Company Information Table 72. Qilu Pharma Business Overview Table 73. Qilu Pharma Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 74. Qilu Pharma Atracurium Besylate Injection Product Portfolio Table 75. Qilu Pharma Recent Development Table 76. Pfizer Company Information Table 77. Pfizer Business Overview Table 78. Pfizer Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 79. Pfizer Atracurium Besylate Injection Product Portfolio Table 80. Pfizer Recent Development Table 81. Hengrui Medicine Company Information Table 82. Hengrui Medicine Business Overview Table 83. Hengrui Medicine Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 84. Hengrui Medicine Atracurium Besylate Injection Product Portfolio Table 85. Hengrui Medicine Recent Development Table 86. GSK Company Information Table 87. GSK Business Overview Table 88. GSK Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 89. GSK Atracurium Besylate Injection Product Portfolio Table 90. GSK Recent Development Table 91. SGPharma Company Information Table 92. SGPharma Business Overview Table 93. SGPharma Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 94. SGPharma Atracurium Besylate Injection Product Portfolio Table 95. SGPharma Recent Development Table 96. Samarth Life Sciences Company Information Table 97. Samarth Life Sciences Business Overview Table 98. Samarth Life Sciences Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 99. Samarth Life Sciences Atracurium Besylate Injection Product Portfolio Table 100. Samarth Life Sciences Recent Development Table 101. Lexicare Pharma Company Information Table 102. Lexicare Pharma Business Overview Table 103. Lexicare Pharma Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 104. Lexicare Pharma Atracurium Besylate Injection Product Portfolio Table 105. Lexicare Pharma Recent Development Table 106. HBM Pharma Company Information Table 107. HBM Pharma Business Overview Table 108. HBM Pharma Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 109. HBM Pharma Atracurium Besylate Injection Product Portfolio Table 110. HBM Pharma Recent Development Table 111. Gland Pharma Company Information Table 112. Gland Pharma Business Overview Table 113. Gland Pharma Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 114. Gland Pharma Atracurium Besylate Injection Product Portfolio Table 115. Gland Pharma Recent Development Table 116. Flagship Biotech Company Information Table 117. Flagship Biotech Business Overview Table 118. Flagship Biotech Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 119. Flagship Biotech Atracurium Besylate Injection Product Portfolio Table 120. Flagship Biotech Recent Development Table 121. Centurion Healthcare Company Information Table 122. Centurion Healthcare Business Overview Table 123. Centurion Healthcare Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 124. Centurion Healthcare Atracurium Besylate Injection Product Portfolio Table 125. Centurion Healthcare Recent Development Table 126. American Remedies Healthcare Company Information Table 127. American Remedies Healthcare Business Overview Table 128. American Remedies Healthcare Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 129. American Remedies Healthcare Atracurium Besylate Injection Product Portfolio Table 130. American Remedies Healthcare Recent Development Table 131. North America Atracurium Besylate Injection Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 132. North America Atracurium Besylate Injection Sales by Country (2021-2026) & (L) Table 133. North America Atracurium Besylate Injection Sales Market Share by Country (2021-2026) Table 134. North America Atracurium Besylate Injection Sales Forecast by Country (2027-2032) & (L) Table 135. North America Atracurium Besylate Injection Sales Market Share Forecast by Country (2027-2032) Table 136. North America Atracurium Besylate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Atracurium Besylate Injection Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Atracurium Besylate Injection Market Share by Country (2021-2026) Table 139. North America Atracurium Besylate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Atracurium Besylate Injection Market Share Forecast by Country (2027-2032) Table 141. Europe Atracurium Besylate Injection Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 142. Europe Atracurium Besylate Injection Sales by Country (2021-2026) & (L) Table 143. Europe Atracurium Besylate Injection Sales Market Share by Country (2021-2026) Table 144. Europe Atracurium Besylate Injection Sales Forecast by Country (2027-2032) & (L) Table 145. Europe Atracurium Besylate Injection Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Atracurium Besylate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Atracurium Besylate Injection Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Atracurium Besylate Injection Market Share by Country (2021-2026) Table 149. Europe Atracurium Besylate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Atracurium Besylate Injection Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Atracurium Besylate Injection Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Atracurium Besylate Injection Sales by Country (2021-2026) & (L) Table 153. Asia-Pacific Atracurium Besylate Injection Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Atracurium Besylate Injection Sales Forecast by Country (2027-2032) & (L) Table 155. Asia-Pacific Atracurium Besylate Injection Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Atracurium Besylate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Atracurium Besylate Injection Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Atracurium Besylate Injection Market Share by Country (2021-2026) Table 159. Asia-Pacific Atracurium Besylate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Atracurium Besylate Injection Market Share Forecast by Country (2027-2032) Table 161. Latin America Atracurium Besylate Injection Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 162. Latin America Atracurium Besylate Injection Sales by Country (2021-2026) & (L) Table 163. Latin America Atracurium Besylate Injection Sales Market Share by Country (2021-2026) Table 164. Latin America Atracurium Besylate Injection Sales Forecast by Country (2027-2032) & (L) Table 165. Latin America Atracurium Besylate Injection Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Atracurium Besylate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Atracurium Besylate Injection Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Atracurium Besylate Injection Market Share by Country (2021-2026) Table 169. Latin America Atracurium Besylate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Atracurium Besylate Injection Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Atracurium Besylate Injection Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Atracurium Besylate Injection Sales by Country (2021-2026) & (L) Table 173. Middle East and Africa Atracurium Besylate Injection Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Atracurium Besylate Injection Sales Forecast by Country (2027-2032) & (L) Table 175. Middle East and Africa Atracurium Besylate Injection Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Atracurium Besylate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Atracurium Besylate Injection Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Atracurium Besylate Injection Market Share by Country (2021-2026) Table 179. Middle East and Africa Atracurium Besylate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Atracurium Besylate Injection Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Atracurium Besylate Injection Distributors List Table 184. Atracurium Besylate Injection Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Atracurium Besylate Injection Image Figure 2. Global Atracurium Besylate Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Atracurium Besylate Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Atracurium Besylate Injection Sales (2021-2032) & (L) Figure 5. 2.5ml:12.5mg Image Figure 6. Global 2.5ml:12.5mg Sales YoY Growth (2021-2032) & (L) Figure 7. 5ml:25mg Image Figure 8. Global 5ml:25mg Sales YoY Growth (2021-2032) & (L) Figure 9. Global Atracurium Besylate Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Atracurium Besylate Injection Market Share by Type 2025 VS 2032 Figure 11. North America Atracurium Besylate Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Atracurium Besylate Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Atracurium Besylate Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Atracurium Besylate Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Atracurium Besylate Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Atracurium Besylate Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Atracurium Besylate Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Atracurium Besylate Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Atracurium Besylate Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Atracurium Besylate Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Atracurium Besylate Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Surgery Image Figure 24. Global Surgery Sales YoY Growth (2021-2032) & (L) Figure 25. Medical Examination Image Figure 26. Global Medical Examination Sales YoY Growth (2021-2032) & (L) Figure 27. Global Atracurium Besylate Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Atracurium Besylate Injection Market Share by Application 2025 VS 2032 Figure 29. North America Atracurium Besylate Injection Sales Market Share in Volume by Application in 2025 Figure 30. North America Atracurium Besylate Injection Sales Market Share in Value by Application in 2025 Figure 31. Europe Atracurium Besylate Injection Sales Market Share in Volume by Application in 2025 Figure 32. Europe Atracurium Besylate Injection Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Atracurium Besylate Injection Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Atracurium Besylate Injection Sales Market Share in Value by Application in 2025 Figure 35. Latin America Atracurium Besylate Injection Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Atracurium Besylate Injection Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Atracurium Besylate Injection Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Atracurium Besylate Injection Sales Market Share in Value by Application in 2025 Figure 39. North America Atracurium Besylate Injection Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 40. North America Atracurium Besylate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Atracurium Besylate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Atracurium Besylate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Atracurium Besylate Injection Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 44. Europe Atracurium Besylate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Atracurium Besylate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Atracurium Besylate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Atracurium Besylate Injection Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 48. Asia-Pacific Atracurium Besylate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Atracurium Besylate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Atracurium Besylate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Atracurium Besylate Injection Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 52. Latin America Atracurium Besylate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Atracurium Besylate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Atracurium Besylate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Atracurium Besylate Injection Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 56. Middle East and Africa Atracurium Besylate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Atracurium Besylate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Atracurium Besylate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Atracurium Besylate Injection Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Atracurium Besylate Injection Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 2.5ml:12.5mg
  • 5ml:25mg
Applications
  • Surgery
  • Medical Examination
Companies covered
  • Qilu Pharma
  • Pfizer
  • Hengrui Medicine
  • GSK
  • SGPharma
  • Samarth Life Sciences
  • Lexicare Pharma
  • HBM Pharma
  • Gland Pharma
  • Flagship Biotech
  • Centurion Healthcare
  • American Remedies Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Atracurium Besylate Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Atracurium Besylate Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Atracurium Besylate Injection Market by Type
  6. 1.3.1 2.5ml:12.5mg
  7. 1.3.2 5ml:25mg
  8. 1.4 Global Atracurium Besylate Injection Market Size by Type
  9. 1.4.1 Global Atracurium Besylate Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Atracurium Besylate Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Atracurium Besylate Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Atracurium Besylate Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Atracurium Besylate Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Atracurium Besylate Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Atracurium Besylate Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Atracurium Besylate Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Atracurium Besylate Injection Industry Trends
  2. 2.2 Atracurium Besylate Injection Industry Drivers
  3. 2.3 Atracurium Besylate Injection Industry Opportunities and Challenges
  4. 2.4 Atracurium Besylate Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Atracurium Besylate Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Atracurium Besylate Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Atracurium Besylate Injection Price (2021-2026)
  4. 3.4 Global Atracurium Besylate Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Atracurium Besylate Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Atracurium Besylate Injection Company, Product Type & Application
  7. 3.7 Global Atracurium Besylate Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Atracurium Besylate Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Atracurium Besylate Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Atracurium Besylate Injection Tier 1, Tier 2, and Tier 3
4 Atracurium Besylate Injection Regional Status and Outlook
  1. 4.1 Global Atracurium Besylate Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Atracurium Besylate Injection Historic Market Size by Region
  3. 4.2.1 Global Atracurium Besylate Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Atracurium Besylate Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Atracurium Besylate Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Atracurium Besylate Injection Forecasted Market Size by Region
  7. 4.3.1 Global Atracurium Besylate Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Atracurium Besylate Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Atracurium Besylate Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Atracurium Besylate Injection by Application
  1. 5.1 Atracurium Besylate Injection Market by Application
  2. 5.1.1 Surgery
  3. 5.1.2 Medical Examination
  4. 5.2 Global Atracurium Besylate Injection Market Size by Application
  5. 5.2.1 Global Atracurium Besylate Injection Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Atracurium Besylate Injection Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Atracurium Besylate Injection Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Atracurium Besylate Injection Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Atracurium Besylate Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Atracurium Besylate Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Atracurium Besylate Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Atracurium Besylate Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Qilu Pharma
  2. 6.1.1 Qilu Pharma Company Information
  3. 6.1.2 Qilu Pharma Business Overview
  4. 6.1.3 Qilu Pharma Atracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Qilu Pharma Atracurium Besylate Injection Product Portfolio
  6. 6.1.5 Qilu Pharma Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Atracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Atracurium Besylate Injection Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 Hengrui Medicine
  14. 6.3.1 Hengrui Medicine Company Information
  15. 6.3.2 Hengrui Medicine Business Overview
  16. 6.3.3 Hengrui Medicine Atracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hengrui Medicine Atracurium Besylate Injection Product Portfolio
  18. 6.3.5 Hengrui Medicine Recent Developments
  19. 6.4 GSK
  20. 6.4.1 GSK Company Information
  21. 6.4.2 GSK Business Overview
  22. 6.4.3 GSK Atracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GSK Atracurium Besylate Injection Product Portfolio
  24. 6.4.5 GSK Recent Developments
  25. 6.5 SGPharma
  26. 6.5.1 SGPharma Company Information
  27. 6.5.2 SGPharma Business Overview
  28. 6.5.3 SGPharma Atracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 SGPharma Atracurium Besylate Injection Product Portfolio
  30. 6.5.5 SGPharma Recent Developments
  31. 6.6 Samarth Life Sciences
  32. 6.6.1 Samarth Life Sciences Company Information
  33. 6.6.2 Samarth Life Sciences Business Overview
  34. 6.6.3 Samarth Life Sciences Atracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Samarth Life Sciences Atracurium Besylate Injection Product Portfolio
  36. 6.6.5 Samarth Life Sciences Recent Developments
  37. 6.7 Lexicare Pharma
  38. 6.7.1 Lexicare Pharma Company Information
  39. 6.7.2 Lexicare Pharma Business Overview
  40. 6.7.3 Lexicare Pharma Atracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Lexicare Pharma Atracurium Besylate Injection Product Portfolio
  42. 6.7.5 Lexicare Pharma Recent Developments
  43. 6.8 HBM Pharma
  44. 6.8.1 HBM Pharma Company Information
  45. 6.8.2 HBM Pharma Business Overview
  46. 6.8.3 HBM Pharma Atracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 HBM Pharma Atracurium Besylate Injection Product Portfolio
  48. 6.8.5 HBM Pharma Recent Developments
  49. 6.9 Gland Pharma
  50. 6.9.1 Gland Pharma Company Information
  51. 6.9.2 Gland Pharma Business Overview
  52. 6.9.3 Gland Pharma Atracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Gland Pharma Atracurium Besylate Injection Product Portfolio
  54. 6.9.5 Gland Pharma Recent Developments
  55. 6.10 Flagship Biotech
  56. 6.10.1 Flagship Biotech Company Information
  57. 6.10.2 Flagship Biotech Business Overview
  58. 6.10.3 Flagship Biotech Atracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Flagship Biotech Atracurium Besylate Injection Product Portfolio
  60. 6.10.5 Flagship Biotech Recent Developments
  61. 6.11 Centurion Healthcare
  62. 6.11.1 Centurion Healthcare Company Information
  63. 6.11.2 Centurion Healthcare Business Overview
  64. 6.11.3 Centurion Healthcare Atracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Centurion Healthcare Atracurium Besylate Injection Product Portfolio
  66. 6.11.5 Centurion Healthcare Recent Developments
  67. 6.12 American Remedies Healthcare
  68. 6.12.1 American Remedies Healthcare Company Information
  69. 6.12.2 American Remedies Healthcare Business Overview
  70. 6.12.3 American Remedies Healthcare Atracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 American Remedies Healthcare Atracurium Besylate Injection Product Portfolio
  72. 6.12.5 American Remedies Healthcare Recent Developments
7 North America by Country
  1. 7.1 North America Atracurium Besylate Injection Sales by Country
  2. 7.1.1 North America Atracurium Besylate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Atracurium Besylate Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Atracurium Besylate Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Atracurium Besylate Injection Market Size by Country
  6. 7.2.1 North America Atracurium Besylate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Atracurium Besylate Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Atracurium Besylate Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Atracurium Besylate Injection Sales by Country
  2. 8.1.1 Europe Atracurium Besylate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Atracurium Besylate Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Atracurium Besylate Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Atracurium Besylate Injection Market Size by Country
  6. 8.2.1 Europe Atracurium Besylate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Atracurium Besylate Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Atracurium Besylate Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Atracurium Besylate Injection Sales by Country
  2. 9.1.1 Asia-Pacific Atracurium Besylate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Atracurium Besylate Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Atracurium Besylate Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Atracurium Besylate Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Atracurium Besylate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Atracurium Besylate Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Atracurium Besylate Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Atracurium Besylate Injection Sales by Country
  2. 10.1.1 South America Atracurium Besylate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Atracurium Besylate Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Atracurium Besylate Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Atracurium Besylate Injection Market Size by Country
  6. 10.2.1 South America Atracurium Besylate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Atracurium Besylate Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Atracurium Besylate Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Atracurium Besylate Injection Sales by Country
  2. 11.1.1 Middle East and Africa Atracurium Besylate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Atracurium Besylate Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Atracurium Besylate Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Atracurium Besylate Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Atracurium Besylate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Atracurium Besylate Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Atracurium Besylate Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Atracurium Besylate Injection Value Chain Analysis
  2. 12.1.1 Atracurium Besylate Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Atracurium Besylate Injection Production Mode & Process
  7. 12.2 Atracurium Besylate Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Atracurium Besylate Injection Distributors
  10. 12.2.3 Atracurium Besylate Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst